Guggenheim Capital’s VectivBio Holding AG Ordinary Shares VECT Stock Holding History

Guggenheim Capital’s Portfolio VECT Stock Details VECT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-15,528	Closed	-$262K	–	1962
2023 Q2	$262K	Buy	+15,528	New	+$204K	﹤0.01%	1703

Other funds holding VECT

RCM

Regency Capital Management Honolulu, Hawaii $251M AUM 32.13% 1-Year Est. Return

SOW

State of Wyoming Cheyenne, Wyoming $989M AUM 52.24% 1-Year Est. Return

Guggenheim Capital's VECT Position: Q3 2023 in Review

Guggenheim Capital sold out of VectivBio Holding AG Ordinary Shares (VECT) in Q3 2023, closing a stake of 15,528 shares — an estimated $262K sold.

Guggenheim Capital first reported a position in VECT in Q2 2023 and held it in 1 quarter. The position peaked at $262K in Q2 2023. 2 funds tracked by Wall St. Rank hold VECT as of Q3 2023.

Guggenheim Capital reported no remaining VectivBio Holding AG Ordinary Shares position as of Q3 2023 after selling out during the quarter.
Guggenheim Capital sold 15,528 VectivBio Holding AG Ordinary Shares shares in Q3 2023, an estimated $262K.
Guggenheim Capital first reported a position in VectivBio Holding AG Ordinary Shares in Q2 2023 and held it in 1 quarter.
Guggenheim Capital's VectivBio Holding AG Ordinary Shares position peaked at $262K in Q2 2023.
2 funds tracked by Wall St. Rank held VectivBio Holding AG Ordinary Shares as of Q3 2023.

Based on Guggenheim Capital's 13F filing for Q3 2023, filed 14 Nov 2023.